Shikonin suppresses the migratory ability of hepatocellular carcinoma cells

Journal of Agricultural and Food Chemistry

Volumn 61, Issue 34, 2013, Pages 8191-8197

  Wei, Po Li ^a,b   Tu, Chao Chiang ^a,b   Chen, Ching Hsein ^e   Ho, Yuan Soon ^b,c,d   Wu, Chun Te ^f,g   Su, Hou Yu ^h   Chen, Wei Yu ⁱ   Liu, Jun Jen ^b   Chang, Yu Jia ^a,b  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Graduate Institute of Clinical Medicine   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^f CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^g CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^h Division of Nephrology   (Taiwan)

ⁱ TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

EMT; HCC; metastasis; migration; vimentin

Indexed keywords

EMT; HCC; METASTASIS; MIGRATION; VIMENTIN;

BIOASSAY; BIOSENSORS; CELLS; PATHOLOGY; PHOSPHORYLATION;

CYTOLOGY;

GELATINASE A; GELATINASE B; HERBACEOUS AGENT; NAPHTHOQUINONE; SHIKONIN;

ARTICLE; CELL MOTION; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LITHOSPERMUM; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PATHOPHYSIOLOGY; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LITHOSPERMUM; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NAPHTHOQUINONES; NEOPLASM METASTASIS;

EID: 84883334460     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf4009586     Document Type: Article

References (43)

1. Kensler, T. W.; Qian, G. S.; Chen, J. G.; Groopman, J. D. Translational strategies for cancer prevention in liver Nat. Rev. Cancer 2003, 3, 321-9
2. El-Serag, H. B.; Rudolph, K. L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 2007, 132, 2557-76
3. Llovet, J. M.; Bruix, J. Molecular targeted therapies in hepatocellular carcinoma Hepatology 2008, 48, 1312-27
4. Poon, R. T.; Ngan, H.; Lo, C. M.; Liu, C. L.; Fan, S. T.; Wong, J. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence J. Surg. Oncol. 2000, 73, 109-14
5. Poon, R. T.; Fan, S. T.; Lo, C. M.; Liu, C. L.; Ng, I. O.; Wong, J. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis J. Clin. Oncol. 2000, 18, 1094-101
6. Poon, R. T.; Fan, S. T.; Ng, I. O.; Wong, J. Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal Ann. Surg. 2000, 231, 544-51
7. el-Assal, O. N.; Yamanoi, A.; Soda, Y.; Yamaguchi, M.; Yu, L.; Nagasue, N. Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma Surgery 1997, 122, 571-7
8. Toyosaka, A.; Okamoto, E.; Mitsunobu, M.; Oriyama, T.; Nakao, N.; Miura, K. Intrahepatic metastases in hepatocellular carcinoma: evidence for spread via the portal vein as an efferent vessel Am. J. Gastroenterol. 1996, 91, 1610-5
9. Price, J. T.; Thompson, E. W. Mechanisms of tumour invasion and metastasis: emerging targets for therapy Expert Opin. Ther. Targets 2002, 6, 217-33
10. Simpson-Haidaris, P. J.; Rybarczyk, B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein Ann. N. Y. Acad. Sci. 2001, 936, 406-25
11. Klein, G.; Vellenga, E.; Fraaije, M. W.; Kamps, W. A.; de Bont, E. S. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia Crit. Rev. Oncol./Hematol. 2004, 50, 87-100
12. Zucker, S.; Vacirca, J. Role of matrix metalloproteinases (MMPs) in colorectal cancer Cancer Metastasis Rev. 2004, 23, 101-17
13. Rao, J. S. Molecular mechanisms of glioma invasiveness: the role of proteases Nat. Rev. Cancer 2003, 3, 489-501
14. Chen, C. H.; Chern, C. L.; Lin, C. C.; Lu, F. J.; Shih, M. K.; Hsieh, P. Y.; Liu, T. Z. Involvement of reactive oxygen species, but not mitochondrial permeability transition in the apoptotic induction of human SK-Hep-1 hepatoma cells by shikonin Planta Med. 2003, 69, 1119-24
15. Gong, K.; Li, W. Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: a potential new treatment for hepatocellular carcinoma Free Radical Biol. Med. 2011, 51, 2259-71
16. Yang, H.; Zhou, P.; Huang, H.; Chen, D.; Ma, N.; Cui, Q. C.; Shen, S.; Dong, W.; Zhang, X.; Lian, W.; Wang, X.; Dou, Q. P.; Liu, J. Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo J. Int. Cancer 2009, 124, 2450-9
17. Yingkun, N.; Lvsong, Z.; Huimin, Y. Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells Can. J. Physiol. Pharmacol. 2010, 88, 1138-46
18. Chiou, J. F.; Tai, C. J.; Huang, M. T.; Wei, P. L.; Wang, Y. H.; An, J.; Wu, C. H.; Liu, T. Z.; Chang, Y. J. Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma Ann. Surg. Oncol. 2010, 17, 603-12
19. Chang, Y. J.; Chiu, C. C.; Wu, C. H.; An, J.; Wu, C. C.; Liu, T. Z.; Wei, P. L.; Huang, M. T. Glucose-regulated protein 78 (GRP78) silencing enhances cell migration but does not influence cell proliferation in hepatocellular carcinoma Ann. Surg. Oncol. 2010, 17, 1703-9
20. Wei, P. L.; Kuo, L. J.; Wang, W.; Lin, F. Y.; Liu, H. H.; How, T.; Ho, Y. S.; Huang, M. T.; Wu, C. H.; Chang, Y. J. Silencing of glucose-regulated protein 78 (GRP78) enhances cell migration through the upregulation of vimentin in hepatocellular carcinoma cells Ann. Surg. Oncol. 2012, 19 (Suppl. 3) S572-9
21. Tai, C. J.; Chin-Sheng, H.; Kuo, L. J.; Wei, P. L.; Lu, H. H.; Chen, H. A.; Liu, T. Z.; Liu, J. J.; Liu, D. Z.; Ho, Y. S.; Wu, C. H.; Chang, Y. J. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells Ann. Surg. Oncol. 2012, 19, 336-43
22. Hung, C. S.; Liu, H. H.; Huang, M. T.; Cheng, C. W.; Kuo, L. J.; Ho, Y. S.; Wu, C. H.; Chen, C. M.; Wei, P. L.; Chang, Y. J. Knockdown survivin expression reduces the efficacy of curcumin treatment in hepatocellular carcinoma cells Ann. Surg. Oncol. 2012, 19, 3547-55
23. Chang, Y. J.; Tai, C. J.; Kuo, L. J.; Wei, P. L.; Liang, H. H.; Liu, T. Z.; Wang, W.; Ho, Y. S.; Wu, C. H.; Huang, M. T. Glucose-regulated protein 78 (GRP78) mediated the efficacy to curcumin treatment on hepatocellular carcinoma Ann. Surg. Oncol. 2011, 18, 2395-403
24. Chang, Y. J.; Huang, Y. P.; Li, Z. L.; Chen, C. H. GRP78 knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells PLoS One 2012, 7, e35123
25. Woessner, J. F., Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling FASEB J. 1991, 5, 2145-54
26. Basset, P.; Okada, A.; Chenard, M. P.; Kannan, R.; Stoll, I.; Anglard, P.; Bellocq, J. P.; Rio, M. C. Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications Matrix Biol. 1997, 15, 535-41
27. Nelson, A. R.; Fingleton, B.; Rothenberg, M. L.; Matrisian, L. M. Matrix metalloproteinases: biologic activity and clinical implications J. Clin. Oncol. 2000, 18, 1135-49
28. Chung, T. W.; Moon, S. K.; Lee, Y. C.; Kim, J. G.; Ko, J. H.; Kim, C. H. Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells Arch. Biochem. Biophys. 2002, 408, 147-54
29. Chung, T. W.; Lee, Y. C.; Ko, J. H.; Kim, C. H. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells Cancer Res. 2003, 63, 3453-8
30. Kohn, E. C.; Liotta, L. A. Molecular insights into cancer invasion: strategies for prevention and intervention Cancer Res. 1995, 55, 1856-62
31. Scorilas, A.; Karameris, A.; Arnogiannaki, N.; Ardavanis, A.; Bassilopoulos, P.; Trangas, T.; Talieri, M. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients Br. J. Cancer 2001, 84, 1488-96
32. Sugita, K. Recent advances in inhibitors of matrix metalloproteinases for cancer therapy IDrugs 1999, 2, 327-39
33. Wojtowicz-Praga, S. Clinical potential of matrix metalloprotease inhibitors Drugs R&D 1999, 1, 117-29
34. Arai, K.; Lee, S. R.; Lo, E. H. Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes Glia 2003, 43, 254-64
35. Chung, T. W.; Lee, Y. C.; Kim, C. H. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential FASEB J. 2004, 18, 1123-5
36. Gum, R.; Wang, H.; Lengyel, E.; Juarez, J.; Boyd, D. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades Oncogene 1997, 14, 1481-93
37. Eberhardt, W.; Huwiler, A.; Beck, K. F.; Walpen, S.; Pfeilschifter, J. Amplification of IL-1 β-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-κB and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways J. Immunol. 2000, 165, 5788-97
38. Abiru, S.; Nakao, K.; Ichikawa, T.; Migita, K.; Shigeno, M.; Sakamoto, M.; Ishikawa, H.; Hamasaki, K.; Nakata, K.; Eguchi, K. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells Hepatology 2002, 35, 1117-24
39. Kim, D.; Kim, S.; Koh, H.; Yoon, S. O.; Chung, A. S.; Cho, K. S.; Chung, J. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production FASEB J. 2001, 15, 1953-62
40. Sato, T.; Koike, L.; Miyata, Y.; Hirata, M.; Mimaki, Y.; Sashida, Y.; Yano, M.; Ito, A. Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells Cancer Res. 2002, 62, 1025-9
41. Pahl, H. L. Activators and target genes of Rel/NF-κB transcription factors Oncogene 1999, 18, 6853-66
42. Garg, A.; Aggarwal, B. B. Nuclear transcription factor-κB as a target for cancer drug development Leukemia 2002, 16, 1053-68
43. Min, R.; Zun, Z.; Min, Y.; Wenhu, D.; Wenjun, Y.; Chenping, Z. Shikonin inhibits tumor invasion via down-regulation of NF-κB-mediated MMP-9 expression in human ACC-M cells Oral Dis. 2011, 17, 362-9